The Board denied an effective date earlier than April 26, 2021 for the award of service connection for graft versus host disease associated with myelofibrosis.
The deciding factor: The July 2014 rating decision was final and not perfected by a substantive appeal. The Veteran's intent to file on April 26, 2021 and subsequent supplemental claim in June 2021 were the first formal claims for service connection after the denial.
- Claimed conditions
- myelofibrosis, graft versus host disease associated with myelofibrosis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- April 17, 2025
- Citation
- A25035574
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Board denied the Veteran's claims for service connection for myelofibrosis and anemia, finding that there was no evidence of a causal relationship between these conditions and his military service.
- Granted
The Board granted service connection for myelofibrosis, finding it to be related to toxic exposure risk activity during the Veteran's active military service.
- Granted
The Board granted service connection for obstructive sleep apnea, effective from the date of the February 2025 rating decision.
- Remanded (sent back)
The Board remands the claim for a medical examination to determine if the Veteran's current neck strain is related to his in-service activities.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.